Before revision: Human HGF plasmid DNA therapy of cardiomyocytes is currently being examined as a potential treatment for coronary artery disease (a major cause of Myocardial infarction (MI)), as well treatment for the damage that occurs to the heart after MI.
After revision: asHuman HGF plasmid DNA therapy of cardiomyocytes is currently being examined as a potential treatment for coronary artery disease (a major cause of Myocardial infarction (MI)), as well treatment for the damage that occurs to the heart after MI.